Skip to main content
Veterinary Medicines

Cenmicin oldatos injekció A.U.V.

Authorised
  • Spectinomycin sulfate
  • Lincomycin hydrochloride

Product identification

Medicine name:
Cenmicin oldatos injekció A.U.V.
Active substance:
  • Spectinomycin sulfate
  • Lincomycin hydrochloride
Target species:
  • Cattle
  • Sheep
  • Pig
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Cenavisa S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 23/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 23/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."